RVNC also reported positive SAKURA-3 data in glabellar lines… PR: https://finance.yahoo.com/news/revance-rt002-demonstrates-unprecedented-efficacy-130500641.html CC slides: https://investors.revance.com/static-files/44313e27-b5bf-46d1-a33d-7b06902860e3